Form 4: Charles River Laboratories Executive Reports Stock Acquisition and Tax-Related Disposition

Victoria L. Creamer, EVP & Chief People Officer of Charles River Laboratories, reported the acquisition of 6,252 common shares as restricted stock units and the disposition of 120 shares for tax purposes.

Summary

• Victoria L. Creamer, Executive Vice President & Chief People Officer of Charles River Laboratories International, Inc. (CRL), filed a Form 4 detailing recent changes in her beneficial ownership.
• On May 30, 2025, Ms. Creamer acquired 6,252 shares of common stock at a price of $135.63 per share.
• These acquired shares are unvested restricted stock units (RSUs) that will vest annually on May 30, 2026, May 30, 2027, May 30, 2028, and May 30, 2029.
• Following this acquisition, Ms. Creamer's beneficial ownership increased to 22,482 shares.
• On May 31, 2025, Ms. Creamer disposed of 120 shares of common stock at a price of $135.63 per share.
• This disposition was marked with transaction code 'F', indicating it was for the payment of an exercise price or tax liability by delivering or withholding securities.
• After the disposition, Ms. Creamer's total beneficial ownership stands at 22,362 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive due to the acquisition of shares (RSUs), which aligns executive interests with the company's long-term performance. The disposition is a standard tax-related event and does not negatively impact sentiment.

Positives

• The acquisition of 6,252 shares, primarily through restricted stock units, aligns the executive's interests with long-term shareholder value.
• The vesting schedule for the restricted stock units extends through May 2029, indicating a long-term commitment of the executive to the company's performance.

Negatives

• The disposition of 120 shares was for tax purposes, which is a routine event and not indicative of a negative outlook on the company.

Future Outlook

The unvested restricted stock units granted to the EVP & Chief People Officer are scheduled to vest annually on May 30th from 2026 through 2029, indicating a long-term incentive structure for the executive.

Industry Context

This Form 4 filing details a routine executive compensation event involving restricted stock units and a tax-related disposition, which is a common practice across various industries for aligning executive incentives with shareholder interests.

Related Party Transactions

• The reported transactions involve an executive (Victoria L. Creamer) and the company (Charles River Laboratories International, Inc.), which are considered related parties in the context of insider transactions.

Stakeholder Impact

• Shareholders: The grant of restricted stock units to a key executive aligns management's long-term interests with those of shareholders, potentially fostering sustained performance.
• Employees: This filing reflects standard executive compensation practices, which can influence overall compensation philosophy within the company.

Next Steps

• Annual vesting of restricted stock units on May 30, 2026, May 30, 2027, May 30, 2028, and May 30, 2029.

Key Dates

Keywords

Charles River Laboratories, CRL, Form 4, Insider Transaction, Stock Ownership, Executive Compensation, Restricted Stock Units, Beneficial Ownership